Aktie A3DP3H BULLFROG AI HOLDINGS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Bullfrog AI Holdings, Inc.

Aktien

A3DP3H

US12021E1091

BFRG

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:00:00 20.05.2024 		% 5 Tage % 1. Jan.
2,89 USD +1,40 % Intraday Chart für Bullfrog AI Holdings, Inc. -3,25 % -11,35 %
16.05. Zusammenarbeit zwischen Bullfrog AI Holdings, Inc. und dem Lieber Institute for Brain Development identifiziert neuartige Wirkstofftargets für neuropsychiatrische Erkrankungen CI
10.05. Bullfrog AI Holdings, Inc. meldet Ergebniszahlen für das erste Quartal zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders
Bullfrog AI Holdings, Inc. and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders
Bullfrog AI Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Certain Pre-Funded Warrants of Bullfrog AI Holdings, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024.
Certain Warrants of Bullfrog AI Holdings, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024.
Certain Common Stock of Bullfrog AI Holdings, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024.
BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo
Bullfrog AI Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute
BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer
Bullfrog AI Holdings, Inc. Appoints Thomas W. Chittenden as Chief Scientific Officer
BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock
BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip
WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public Offering
BullFrog AI Announces Closing of $5.7 Million Public Offering
Bullfrog AI Holdings Prices $5.7 Million Public Stock Offering; Shares Fall
WallachBeth Capital Announces Bullfrog AI Pricing of $5.7 Million Public Offering
Bullfrog AI Announces Pricing of $5.7 Million Public Offering
Top Premarket Decliners
Bullfrog AI Holdings, Inc. Appoints Gwenn S. Smith and Jeremiah Wala to Its Advisory Board
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DP3H Aktie
  4. Nachrichten Bullfrog AI Holdings, Inc.
  5. Andere Sprachen